Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

GlcB (M. Tuberculosis) Antikörper

Der Kaninchen Polyklonal Anti--Antikörper wurde für ELISA und WB validiert. Er ist geeignet, in Proben von Mycobacterium tuberculosis zu detektieren.
Produktnummer ABIN361286

Kurzübersicht für GlcB (M. Tuberculosis) Antikörper (ABIN361286)

Target

GlcB (M. Tuberculosis)

Reaktivität

Mycobacterium tuberculosis

Wirt

Kaninchen

Klonalität

Polyklonal

Applikation

ELISA, Western Blotting (WB)
  • Verwendungszweck

    Anti-GlcB (M. tuberculosis) Purified

    Spezifität

    The rabbit polyclonal antibody to GlcB reacts with Mycobacterium tuberculosis protein GlcB (malate synthase, Rv1837c).

    Aufreinigung

    Purified by ligand affinity chromatography.

    Reinheit

    > 95 % (by SDS-PAGE)

    Immunogen

    Recombinant GlcB protein (produced in E. coli)

    Isotyp

    IgG
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1 mg/mL

    Buffer

    Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C

    Informationen zur Lagerung

    Store at 2-8°C. Do not freeze.
  • Target

    GlcB (M. Tuberculosis)

    Hintergrund

    Malate synthase,The Mycobacterium tuberculosis antigen GlcB (malate synthase) catalyzes synthesis of malate from glyoxylate and acetyl-CoA. This reaction is part of the glyoxylate cycle, which allows the bacterium to derive its carbon requirements from two-carbon compounds by bypassing the two carbocylation steps of the cytric acid cycle. This enzyme is up-regulated in response to phagocytosis and it is a virulence or persistence factor.,Rv1837c

    Gen-ID

    885713

    UniProt

    P9WK17
Sie sind hier:
Chat with us!